FDA Import Refusal AEK-2027330-5/20003/1 — GLENMARK PHARMACEUTICALS LTD
The FDA refused shipment AEK-2027330-5/20003/1 from GLENMARK PHARMACEUTICALS LTD (India) on Oct 21, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 21, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75